These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15635868)

  • 1. [Treatment of AL-amyloidosis and some other types of amyloidosis].
    Adam Z; Scudla V; Tomíska M
    Vnitr Lek; 2001 Jan; 47(1):46-52. PubMed ID: 15635868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
    Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T
    Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
    Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
    Leung N; Dispenzieri A; Fervenza FC; Lacy MQ; Villicana R; Cavalcante JL; Gertz MA
    Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autologous stem cell transplantation in the treatment of primary systemic amyloidosis].
    Gil L; Komarnicki M
    Pol Merkur Lekarski; 2009 Sep; 27(159):181-4. PubMed ID: 19827724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment in systemic amyloidosis].
    Ikeda S
    Rinsho Byori; 2008 Feb; 56(2):121-9. PubMed ID: 18404826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experience.
    Chow LQ; Bahlis N; Russell J; Chaudhry A; Morris D; Brown C; Stewart DA
    Bone Marrow Transplant; 2005 Oct; 36(7):591-6. PubMed ID: 16062177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of amyloidosis].
    Wien TN
    Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1397-400. PubMed ID: 18552901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary amyloidosis in hematological disorders.
    Cordier JF
    Semin Respir Crit Care Med; 2005 Oct; 26(5):502-13. PubMed ID: 16267701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?
    Bahlis NJ; Lazarus HM
    Bone Marrow Transplant; 2006 Jul; 38(1):7-15. PubMed ID: 16715110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal manifestations of amyloidosis.
    Ebert EC; Nagar M
    Am J Gastroenterol; 2008 Mar; 103(3):776-87. PubMed ID: 18076735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term survival after autologous peripheral blood stem cell transplantation in a patient with primary AL amyloidosis complicating congestive heart failure].
    Saito M; Hayashi T; Nojima M; Ikeda H; Tarasawa I; Yasui H; Ishida T; Adachi M; Imai K; Shinomura Y
    Rinsho Ketsueki; 2007 Nov; 48(11):1478-83. PubMed ID: 18080505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-dose treatment of systemic AL-amyloidosis with autologous stem cell support].
    Schjesvold FH; Sjo M; Tangen JM; Hammerstrøm J; Brinch L
    Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1392-6. PubMed ID: 18552900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study.
    Bird JM; Fuge R; Sirohi B; Apperley JF; Hunter A; Snowden J; Mahendra P; Milligan D; Byrne J; Littlewood T; Fegan C; McQuaker G; Pagliuca A; Johnson P; Rahemtulla A; Morris C; Marks DI;
    Br J Haematol; 2006 Aug; 134(4):385-90. PubMed ID: 16822294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AL amyloidosis manifesting as systemic lymphadenopathy.
    Matsuda M; Gono T; Shimojima Y; Yoshida T; Katoh N; Hoshii Y; Yamada T; Ikeda S
    Amyloid; 2008 Jun; 15(2):117-24. PubMed ID: 18484338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal involvement in amyloidosis. Clinical outcomes, evolution and survival].
    Esteve V; Almirall J; Ponz E; García N; Ribera L; Larrosa M; Andreu X; García M
    Nefrologia; 2006; 26(2):212-7. PubMed ID: 16808259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone.
    Kastritis E; Anagnostopoulos A; Roussou M; Toumanidis S; Pamboukas C; Migkou M; Tassidou A; Xilouri I; Delibasi S; Psimenou E; Mellou S; Terpos E; Nanas J; Dimopoulos MA
    Haematologica; 2007 Oct; 92(10):1351-8. PubMed ID: 18024372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of primary amyloidosis].
    Ardashev VN; Potekhin NP; Rukavitsyn OA; Borisov AG; Malysheva SA
    Klin Med (Mosk); 2006; 84(6):56-9. PubMed ID: 16875072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
    Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
    Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.